Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11707448 Combination therapies for the treatment of cancer

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

July 25, 2023

0

Patent Application Number

175285100

Date Filed

November 17, 2021

0

Patent Citations

US Patent 8354509 Antibodies to human programmed death receptor PD-1

0

US Patent 8383796 Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)

0

US Patent 8552154 Anti-PD-L1 antibodies and uses therefor

0

US Patent 8617546 Anticancer agent comprising anti-PD-1 antibody or anti-PD-L1 antibody

0

US Patent 8685394 Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases

0

US Patent 8686018 Pharmaceutical composition

0

US Patent 8709417 Combination immunotherapy for the treatment of cancer

0

US Patent 9000024 Pharmaceutical composition

0

...

Patent Primary Examiner

Jeffrey S Lundgren

0

CPC Code

0

0

0

0

0

0

0

The present invention provides methods and compositions for treating cancer by administering an EP4 antagonist in combination with radiation therapy, antibody therapy and/or anti-metabolite chemotherapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11707448 Combination therapies for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.